TSPO has recently been identified as a potential biomarker of neurodegeneration since its expression increases with inflammation and neurodegeneration associated with Alzheimer’s disease, HIV encephalitis, and MS. The gene discussed is TSPO; the disease is early-onset autosomal dominant Alzheimer disease.